Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results| (NASDAQ: CRVS) | Delayed: 12.68 +0.45 (3.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.23 | 52 Week High | $17.77 | |||
| Open | $12.55 | 52 Week Low | $9.63 | |||
| Day High | $12.69 | P/E | N/A | |||
| Day Low | $12.43 | EPS | $0.00 | |||
| Volume | 211,338 | |||||

